Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Learn about the key financial habits for success that can pave the way to wealth. Start building these habits today!
26,788 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
A new wave of investors is changing how rental markets work. Out-of-town buyers are driving rental demand in many top...
A once-dismissed Google-backed AI fund has closed a $220 million fifth fund, illustrating how the seeds of AI investi...
Oklo stock popped today after a regulatory milestone signaled progress for the company’s Aurora fast-fission technolo...
Big funds sometimes trim stakes in the market's most valuable names. This article breaks down why institutional inves...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
The AI boom often centers on GPUs and big models, but the true mover is the network that ties data and compute togeth...
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Is Lilly stock undervalued healthcare? This article breaks down the valuation case, growth catalysts, risks, and a pr...